Islam T, Lynn BC, Markesbery WR, Lovell MA
Consider tirzepatide (Zepbound/Mounjaro) if: You want a proven, FDA-approved medication available today You prefer a drug with years of real-world safety data You have insurance coverage for weight management medications You have type 2 diabetes (Mounjaro is indicated for T2D) You are sensitive to GI side effects (lower nausea rate: 31% vs 43%) You want the option of pre-filled pens for easier injection Consider waiting for retatrutide if: You have plateaued on tirzepatide or semaglutide and want the next-generation option You have MASLD or fatty liver disease (glucagon component reduces liver fat by 82%) Maximum possible weight loss is your primary goal You are eligible for and enrolled in a clinical trial You are comfortable waiting until 2027-2028 for availability On switching from tirzepatide to retatrutide: Once retatrutide is approved, switching will likely be straightforward since both are Lilly products

B Complex Injection generally does not interact with other medications, but it is important to inform your healthcare provider about all medications and supplements you are taking to ensure there are no potential interactions
Nutrition Insight recently sat down with experts to discuss how the industry can bridge this gap in digestive health
However, it is crucial to understand that there is no official clinical link established between Ozempic and direct dental damage, and as of 2023, no specific dental warnings appear in the official product information